List of our scientific contributions.


  • Meier C., Freiburghaus K.; Bovet C., Schniering J., Allanore Y., Distler O., Nakas C., Maurer B. Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease. Scientific reports, 10(1), 21912, doi: 10.1038/s41598-020-78951-6 (2020)
  • Reverter-Branchat G., Groessl M., Nakas C.T., Prost J.-C., Antwi K., Niederkofler E.E., Bally L. Rapid quantification of insulin degludec by immunopurification combined with liquid chromatography high-resolution mass spectrometry, Anal. Bioanal. Chem. 412, 8351-8359 (2020)
  • Freiburghaus K., Leichtle A.B., Nakas C.T., Fiedler G.M. and Largiadèr C.R., Effects of Freezing and Thawing Procedures on Selected Clinical Chemistry Parameters in Plasma, Biopreservation and Biobanking (2020) doi: 10.1089/bio.2020.0005
  • Herzig D, Dehais J, Prost J.C, Nakas CT, Stettler C, Bally L, Hovorka R. Pharmacokinetics of faster and standard insulin aspart during fully closed-loop insulin delivery in type 2 diabetes. Diabetes Technol Ther. (2020) doi: 10.1089/dia.2019.0477


  • Sutter D., Dzhonova D.V., Prost J.C., Bovet C., Banz Y., Rahnfeld L., Leroux J.-C., Rieben R., Vögelin E., Plock J. A., Luciani P., Taddeo A., Schnider J. T. Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival, Sci Rep 9, 9269 (2019). Nature 10.1038/s41598-019-45759-y
  • Freiburghaus K., Largiadèr C. R., Stettler C., Fiedler G. M., Bally L., Bovet C. (2019). Metabolomics by UHPLC-MS: benefits provided by complementary use of Q-TOF and QQQ for pathway profiling. Metabolomics, 15(9), 120 doi: 10.1007/s11306-019-1585-3
  • Zoni E., Minoli M., Bovet C., Wehrhan A., Piscuoglio S., Ng C. K. Y., Gray P. C., Spahn M., Thalmann G. N., Kruithof-de Julio M. Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification, BMC Cancer 19, 1216 (2019) doi:10.1186/s12885-019-6418-2
  • Liu H., He Z., Germič N., Ademi H., Frangež Ž., Felser A., Peng S., Riether C., Djonov V., Nuoffer J.-M., Bovet C., Mlinarič-Raščan I., Zlobec I., Fiedler M., Perren A., Simon H.-U. ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics, Cell Death Differ (2019) doi:10.1038/s41418-019-0476-5


  • Dzhonova D., Olariu R., Leckenby J., Dhayani A., Vemula P.K., Prost J.-C., Banz Y., Taddeo A., Rieben R., Local release of tacrolimus from hydrogel-based drug delivery system is controlled by inflammatory enzymes in vivo and can be monitored non-invasively using in vivo imaging, PLoS One, 2018. doi: 10.1371/journal.pone.0203409
  • Dzhonova D. V., Olariu R., Leckenby J., Banz Y., Prost, J.-C., Dhayani A., Vemula P.K., Voegelin, E., Taddeo A., Rieben R. Local injections of tacrolimus-loaded hydrogel reduce systemic immunosuppression-related toxicity in vascularized composite allotransplantation. Transplantation 2018. doi: 10.1097/TP.0000000000002283
  • Rindlisbacher B., Schmid C., Geiser T., Bovet C., Funke M. Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC. Respiratory Research 2018. doi: 10.1186/s12931-018-0714-2


  • Rindlisbacher B., Strebel C., Guler S.A., Kollar A., Geiser T.K., Fiedler G.M., Leichtle A.B., Bovet C., Funke M. Exhaled breath condensate as a potential biomarker tool for idiopathic pulmonary fibrosis - a pilot study. J Breath Res. 2017. doi: 10.1088/1752-7163/aa840a.
  • Bally L., Bovet C., Nakas C.T., Zueger T., Prost J.C., Nuoffer J.M., Leichtle A.B., Fiedler G.M., Stettler C. A metabolomics approach to uncover effects of different exercise modalities in type 1 diabetes. Metabolomics 2017, 13: 78. doi: 10.1007/s11306-017-1217-8
  • Prost, J.-C., Brunner, F., Bovet, C., Grob, C., Berchtold, C., Schlotterbeck, G., Kröll, D., Largiadèr, C. R., Fiedler, G. M., Juillerat, P. A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption. Clinical Mass Spectrometry 2017, 3, 1-6. doi: 10.1016/j.clinms.2017.02.001
  • Hilmenyuk T., Ruckstuhl C.A., Hayoz M., Berchtold C., Nuoffer J.M., Solanki S., Keun H.C., Beavis P.A., Riether C., Ochsenbein A.F. T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma. OncoImmunology 2017 doi:10.1080/2162402X.2017.1365997